Shaken, Not Stirred: Remdisivir and anti-viral Drug Cocktail give hope in the battle against COVID-19
Thanks in part to several Stanford University doctors, the FDA has granted emergency use authorization of the drug remdesivir to treat severely ill patients in the hospital. Under normal circumstances, drug studies and clinical trials would take years, but the Gilead and NIH studies took less than two months and show that 31 percent of patients who take remdesivir improve. "We want to thank all the collaborators that have brought […]
